Welcome to PepGuide, the most comprehensive peptide guide and research hub available for serious researchers, biohackers, and health optimizers. PepGuide (pepguide.xyz) exists to give you accurate, evidence-based information drawn from peer-reviewed literature and the broader research community. Whether you are just beginning to explore the science of research peptides or you are a seasoned investigator looking to refine your protocols, this reference hub covers everything from peptide classification and mechanism of action to reconstitution protocols, dosing strategies, storage best practices, safety considerations, and the evolving regulatory landscape. Think of this as your foundational starting point and your ongoing reference as the field continues to develop at a rapid pace.
What Is PepGuide and Why This Peptide Guide Exists
PepGuide was built to solve a specific problem: the peptide research space is vast, fragmented, and often filled with low-quality information that blends anecdotal reports with misrepresented clinical data. Researchers need a centralized, trustworthy peptide guide that respects the complexity of the science while remaining accessible to those without a formal biochemistry background. This research hub aggregates the best available evidence from sources like PubMed and the NIH, synthesizes community-driven biohacker data, and presents it in a format that supports informed decision-making rather than reckless self-experimentation.
The peptide landscape encompasses hundreds of compounds, each with unique receptor binding profiles, administration routes, half-lives, and research applications. PepGuide organizes this complexity into structured, navigable content so that you can quickly find the information most relevant to your specific area of interest, whether that is tissue repair, cognitive enhancement, metabolic optimization, growth hormone modulation, or longevity research.
Understanding Peptide Classification Systems
Before diving into specific compounds, it is essential to understand how peptides are classified. Peptides are short chains of amino acids linked by peptide bonds, typically defined as containing between 2 and 50 amino acids. Beyond that structural definition, classification systems diverge based on function, origin, and mechanism of action.
Classification by Function
Functional classification groups peptides by what they are primarily studied to do in research contexts. Growth hormone secretagogues like Ipamorelin, CJC-1295, Sermorelin, GHRP-6, and GHRP-2 are classified together because they act on the growth hormone axis, albeit through different receptor pathways. Tissue repair and regenerative peptides such as BPC-157 and TB-500 are grouped based on their studied influence on healing cascades. Metabolic peptides including Semaglutide and Tirzepatide operate on incretin hormone pathways. Nootropic peptides such as Selank and Semax are classified by their proposed cognitive and neurological research applications. Finally, longevity and anti-aging peptides like Epithalon and GHK-Cu are grouped around their influence on cellular repair mechanisms and skin biology.
Classification by Origin
Peptides can also be classified by their origin. Endogenous peptides occur naturally in the human body and include compounds like Thymosin Beta-4, which TB-500 is derived from. Synthetic analogs are engineered to mimic or enhance the activity of natural peptides, often with improved stability or bioavailability. For example, CJC-1295 is a synthetic GHRH analog designed to extend the half-life of natural growth hormone-releasing hormone. Naturally derived peptides include GHK-Cu, a tripeptide found in human plasma that has been studied for its role in tissue remodeling and skin repair.
How Research Peptides Work: Mechanisms and Receptor Binding
Understanding how research peptides exert their effects requires a working knowledge of receptor biology and signaling pathways. Most research peptides work by binding to specific receptors on cell surfaces, triggering intracellular signaling cascades that produce downstream biological effects. The specificity of receptor binding is one of the most important properties distinguishing different peptide classes.
Growth hormone secretagogues operate primarily through two receptor systems. GHRH analogs like Sermorelin and CJC-1295 bind to the growth hormone-releasing hormone receptor (GHRHR) on pituitary somatotroph cells, stimulating pulsatile release of growth hormone. GHRPs such as GHRP-6 and GHRP-2 bind to the ghrelin receptor (GHS-R1a), which amplifies GH secretion through a complementary but distinct pathway. This is precisely why the combination of a GHRH analog and a GHRP, such as the widely studied Ipamorelin and CJC-1295 stack, produces a synergistic pulsatile release pattern that more closely mimics physiological GH secretion than either compound alone.
Metabolic peptides work through incretin hormone receptors. Semaglutide is a GLP-1 receptor agonist, binding to glucagon-like peptide-1 receptors in the pancreas, gut, and brain to modulate insulin secretion, gastric emptying, and satiety signaling. Tirzepatide expands on this by acting as a dual GIP and GLP-1 receptor agonist, targeting both the glucose-dependent insulinotropic polypeptide receptor and the GLP-1 receptor simultaneously, which has made it one of the most studied compounds in current metabolic research.
PT-141, also known as Bremelanotide, operates on melanocortin receptors, specifically MC3R and MC4R in the central nervous system, distinguishing it from compounds that act on peripheral vascular mechanisms. BPC-157, the flagship healing peptide, has been studied for its interactions with multiple receptor systems including nitric oxide pathways, growth factor receptors, and the dopaminergic system, which may partially explain its broad range of studied applications in tissue repair research.
The Most Studied Peptides in Current Research
BPC-157: The Flagship Healing Peptide
BPC-157, or Body Protection Compound 157, is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It has accumulated one of the most extensive bodies of preclinical research of any research peptide, with studies examining its role in tissue repair for tendons, ligaments, muscles, bone, and gastrointestinal tissue. Research has consistently shown BPC-157 to accelerate healing in animal models through mechanisms including upregulation of growth hormone receptors, promotion of angiogenesis, and modulation of nitric oxide synthesis. While human clinical trial data remains limited compared to animal study data, BPC-157 is among the most discussed and researched compounds within the peptide research community due to the breadth and consistency of preclinical findings.
TB-500: Thymosin Beta-4 Fragment
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide that plays a critical role in actin regulation, cell migration, and tissue regeneration. Research has focused on TB-500 for its studied ability to promote tissue repair and reduce inflammation in injured tissue, particularly in contexts involving cardiac muscle, skeletal muscle, and connective tissue. TB-500 is often examined alongside BPC-157 in stacking research, as their complementary mechanisms of action in tissue repair research make them a frequently discussed combination in both scientific literature and biohacker communities.
Ipamorelin and CJC-1295: The GH Stack
Ipamorelin is widely regarded as one of the most selective growth hormone secretagogues available for research. Unlike GHRP-6 and GHRP-2, which can significantly increase cortisol and prolactin secretion in addition to GH, Ipamorelin produces a highly selective GH pulse with minimal effects on these other hormones. This selectivity makes it a preferred compound in growth hormone secretagogue research. When combined with CJC-1295, a GHRH analog that extends the half-life of growth hormone-releasing hormone signaling through a drug affinity complex mechanism, the resulting Ipamorelin and CJC-1295 stack is considered one of the most studied and discussed GH secretagogue combinations in current research literature.
Semaglutide and Tirzepatide: Metabolic Research Peptides
Semaglutide and Tirzepatide represent the leading edge of metabolic peptide research. As a GLP-1 receptor agonist, Semaglutide has advanced through rigorous clinical trials and received regulatory approval in pharmaceutical form for specific indications. In the research context, it is studied for its mechanisms of appetite regulation, glucose homeostasis, and cardiometabolic effects. Tirzepatide, as a dual GIP/GLP-1 agonist, has generated significant research interest for its apparently superior efficacy in metabolic outcomes compared to single-agonist GLP-1 compounds, making it one of the fastest-growing areas of metabolic peptide investigation.
Epithalon and GHK-Cu: Longevity and Regenerative Research
Epithalon, also spelled Epitalon, is a synthetic tetrapeptide studied primarily for its proposed effects on telomerase activation and telomere elongation in cellular research. Research originating largely from Russian scientific institutions suggests that Epithalon may modulate the neuroendocrine system and influence longevity biomarkers, though this area of research requires significantly more independent validation. GHK-Cu, a copper peptide tripeptide complex, has been studied extensively in the context of skin biology, wound healing, and tissue remodeling. Its ability to promote collagen synthesis and support antioxidant defense mechanisms has made it a prominent subject in both dermatological research and broader regenerative medicine investigations.
Peptide Reconstitution Protocols: A PepGuide Primer
Proper reconstitution is one of the most important practical skills for any peptide researcher, and it is an area where errors are common and consequential. Most research peptides are supplied as lyophilized (freeze-dried) powder and must be reconstituted with a sterile diluent before use. The most commonly used diluents are bacteriostatic water (BAC water), which contains 0.9% benzyl alcohol as a preservative and extends the usable life of a reconstituted peptide, and sterile water for injection, which is preservative-free and should be used when bacteriostatic water is contraindicated by the specific compound.
The general reconstitution procedure involves drawing the appropriate volume of diluent into a sterile syringe, injecting it slowly down the inside wall of the vial rather than directly onto the peptide powder to avoid mechanical degradation, and then gently swirling rather than shaking the vial until the powder is fully dissolved. Vigorous shaking can disrupt the peptide structure and reduce biological activity. Once reconstituted, most research peptides should be stored at 2 to 8 degrees Celsius in a refrigerator and protected from light exposure.
Calculating the correct concentration after reconstitution is an essential skill. If a vial contains 5 mg of lyophilized peptide and you add 2 mL of bacteriostatic water, the resulting concentration is 2.5 mg per mL, or 2,500 mcg per mL. Understanding this calculation allows researchers to determine accurate volumes for drawing specific doses. Using an insulin syringe calibrated in units simplifies this process considerably, with 100 units equaling 1 mL on a standard U-100 insulin syringe.
Administration Routes for Research Peptides
The route of administration has a significant impact on the bioavailability, onset of action, and half-life of any given research peptide. Understanding the distinctions between administration routes is a core element of building sound research protocols, and this peptide guide covers the most relevant options in detail.
Subcutaneous Administration
Subcutaneous (SubQ) injection involves delivering the peptide into the layer of fat just below the skin, typically at sites such as the abdomen, thigh, or lower flank. This is the most common administration route for the majority of research peptides including BPC-157, TB-500, Ipamorelin, CJC-1295, and the GLP-1 class compounds. SubQ administration provides relatively consistent absorption kinetics and is generally well-tolerated in research settings. The onset of action is typically slower than intravenous delivery but more predictable than oral routes for peptides that are susceptible to gastrointestinal degradation.
Intramuscular Administration
Intramuscular (IM) injection delivers the peptide directly into muscle tissue, typically in the deltoid, vastus lateralis, or gluteal region. Some researchers prefer intramuscular administration for TB-500 and certain other peptides due to the potentially faster absorption from well-vascularized muscle tissue. IM injection requires careful attention to injection site rotation and proper technique to minimize the risk of local tissue reactions.
Oral and Intranasal Routes
Oral administration of peptides is challenged by the fact that most peptides are rapidly degraded by proteolytic enzymes in the gastrointestinal tract before they can reach systemic circulation. However, certain peptides are specifically studied for oral bioavailability. BPC-157 is a notable example, with some preclinical research suggesting meaningful oral activity, likely related to its proposed mechanism of action within the gastrointestinal mucosa itself. Intranasal delivery has been studied for nootropic peptides including Semax and Selank, where direct absorption through the nasal mucosa may allow compounds to bypass the blood-brain barrier more efficiently than systemic injection routes.
Peptide Half-Lives and Dosing Frequency Considerations
A peptide's half-life, defined as the time required for the plasma concentration to fall to half of its initial value, directly determines the appropriate dosing frequency in any research protocol. Peptides with short half-lives require more frequent administration to maintain consistent receptor activation, while longer-acting analogs can be dosed less frequently.
Ipamorelin has a reported half-life of approximately 2 hours, which is why research protocols frequently examine its administration two to three times daily to achieve multiple GH pulses across the day. Native GHRH has an even shorter half-life of only a few minutes, which is precisely the problem that CJC-1295 was engineered to solve. CJC-1295 without DAC has a half-life of approximately 30 minutes, while CJC-1295 with the Drug Affinity Complex (DAC) modification extends the half-life to approximately 6 to 8 days, enabling once-weekly dosing schedules in research protocols.
Semaglutide's extended half-life of approximately 7 days, achieved through albumin binding modifications and a fatty acid chain, is what enables its once-weekly subcutaneous injection schedule in clinical use and research settings. BPC-157 has a relatively short half-life in plasma, which has led to research interest in both its oral and injectable forms depending on the target tissue being investigated. Understanding half-life data helps researchers design protocols that maintain biologically relevant compound concentrations at the target receptor without unnecessary over-administration.
Peptide Stacking Strategies in Research Protocols
Peptide stacking refers to the concurrent use of two or more research peptides within a protocol, based on the hypothesis that their complementary mechanisms of action may produce additive or synergistic effects. Stacking strategies are a prominent area of discussion within the biohacker and peptide research community, though it is important to note that formal clinical research on most specific peptide combinations remains limited.
The BPC-157 and TB-500 stack is among the most widely discussed combinations in tissue repair research. BPC-157's proposed mechanisms related to growth factor signaling and angiogenesis and TB-500's role in actin regulation and cell migration are theoretically complementary in the context of accelerating healing cascades. Researchers frequently examine this combination for musculoskeletal injury recovery applications.
The Ipamorelin and CJC-1295 stack represents the dominant approach in growth hormone secretagogue research because the two compounds operate through distinct but synergistic receptor pathways. CJC-1295 stimulates the GHRHR to prime the pituitary, while Ipamorelin acts on the ghrelin receptor to amplify the resulting GH pulse. Research suggests this combination produces GH release patterns that more closely approximate natural physiological pulsatility than either compound alone.
Researchers exploring cognitive applications may examine stacks combining Semax with Selank, as the former is primarily studied for its nootropic and neuroprotective properties while the latter is studied for its anxiolytic and immune-modulating effects. When designing any stacking protocol, it is essential to consider the interaction of receptor systems, the timing of administration relative to each compound's half-life, and the potential for compounded side effect profiles that would not be apparent from single-compound research.
Peptide Storage, Stability, and Quality Considerations
The stability of research peptides is highly sensitive to storage conditions, and improper handling is one of the most common sources of degraded research outcomes. Lyophilized peptide powder is generally more stable than reconstituted solution and can often be stored at room temperature for short periods, though refrigeration at 2 to 8 degrees Celsius is preferable for storage periods beyond a few days. For long-term storage of lyophilized peptides exceeding several months, freezing at -20 degrees Celsius is recommended by most manufacturers and researchers.
Once reconstituted, the storage requirements become more stringent. Reconstituted peptide solutions should be kept at 2 to 8 degrees Celsius, protected from light, and used within the timeframe indicated by the specific compound's known stability profile. Peptides reconstituted in bacteriostatic water generally remain stable for 4 to 6 weeks when properly refrigerated, while those reconstituted in sterile water should typically be used within a shorter window and in some cases immediately.
Sourcing quality is a critical variable that this peptide guide cannot overstate. The research peptide market contains a wide spectrum of supplier quality, and the purity, concentration accuracy, and sterility of research peptides vary considerably between vendors. Researchers should prioritize suppliers who provide third-party certificates of analysis (COAs) from accredited independent laboratories, with high-performance liquid chromatography (HPLC) purity data and mass spectrometry confirmation of the correct molecular identity. Avoiding suppliers who cannot or will not provide current COA documentation is a fundamental quality control principle for serious research applications.
Safety Considerations and the Regulatory Landscape
No comprehensive peptide guide would be complete without a frank discussion of safety considerations and the regulatory environment that governs research peptides. The safety profile of any given research peptide is determined by the totality of available evidence, which for most compounds in this space means primarily preclinical animal studies with limited or no human clinical trial data. This distinction is fundamental: a favorable safety signal in rodent studies does not automatically translate to equivalent safety in human applications.
The most commonly reported adverse effects associated with injectable research peptides include injection site reactions such as redness, swelling,